BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oussalah A, Guéant JL, Peyrin-Biroulet L. Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases. Aliment Pharmacol Ther 2011;34:1173-84. [PMID: 21967576 DOI: 10.1111/j.1365-2036.2011.04864.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 66] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Kalkan G, Karakus N, Yigit S. Association of MTHFR gene C677T mutation with recurrent aphthous stomatitis and number of oral ulcers. Clin Oral Invest 2014;18:437-41. [DOI: 10.1007/s00784-013-0997-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
2 Owczarek D, Cibor D, Głowacki MK, Rodacki T, Mach T. Inflammatory bowel disease: Epidemiology, pathology and risk factors for hypercoagulability. World J Gastroenterol 2014; 20(1): 53-63 [PMID: 24415858 DOI: 10.3748/wjg.v20.i1.53] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
3 Ratajczak AE, Szymczak-Tomczak A, Rychter AM, Zawada A, Dobrowolska A, Krela-Kaźmierczak I. Does Folic Acid Protect Patients with Inflammatory Bowel Disease from Complications? Nutrients 2021;13:4036. [PMID: 34836291 DOI: 10.3390/nu13114036] [Reference Citation Analysis]
4 Kilby K, Mathias H, Boisvenue L, Heisler C, Jones JL. Micronutrient Absorption and Related Outcomes in People with Inflammatory Bowel Disease: A Review. Nutrients 2019;11:E1388. [PMID: 31226828 DOI: 10.3390/nu11061388] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
5 Huang Q, Zhang X, Hu Z. Application of Artificial Intelligence Modeling Technology Based on Multi-Omics in Noninvasive Diagnosis of Inflammatory Bowel Disease. J Inflamm Res 2021;14:1933-43. [PMID: 34017190 DOI: 10.2147/JIR.S306816] [Reference Citation Analysis]
6 Givvimani S, Munjal C, Narayanan N, Aqil F, Tyagi G, Metreveli N, Tyagi SC. Hyperhomocysteinemia decreases intestinal motility leading to constipation. Am J Physiol Gastrointest Liver Physiol 2012;303:G281-90. [PMID: 22595990 DOI: 10.1152/ajpgi.00423.2011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
7 Saito M, Marumo K. Effects of Collagen Crosslinking on Bone Material Properties in Health and Disease. Calcif Tissue Int. 2015;97:242-261. [PMID: 25791570 DOI: 10.1007/s00223-015-9985-5] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 10.1] [Reference Citation Analysis]
8 Solitano V, Fiorino G, D'Amico F, Peyrin-Biroulet L, Danese S. Thrombosis in IBD in the Era of JAK Inhibition. Curr Drug Targets 2021;22:126-36. [PMID: 32881668 DOI: 10.2174/1389450121666200902164240] [Reference Citation Analysis]
9 Yamane S, Nomura R, Yanagihara M, Nakamura H, Fujino H, Matsumoto K, Horie S, Murayama T. L-cysteine/d,L-homocysteine-regulated ileum motility via system L and B°,+ transporter: Modification by inhibitors of hydrogen sulfide synthesis and dietary treatments. European Journal of Pharmacology 2015;764:471-9. [DOI: 10.1016/j.ejphar.2015.07.042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
10 Singh S, Singh H, Loftus EV, Pardi DS. Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014;12:382-93.e1: quiz e22. [PMID: 23978350 DOI: 10.1016/j.cgh.2013.08.023] [Cited by in Crossref: 124] [Cited by in F6Publishing: 111] [Article Influence: 13.8] [Reference Citation Analysis]
11 Mullin GE. Micronutrients and inflammatory bowel disease. Nutr Clin Pract. 2012;27:136-137. [PMID: 22223669 DOI: 10.1177/0884533611433436] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
12 Wu P, Jia F, Zhang B, Zhang P. Risk of cardiovascular disease in inflammatory bowel disease. Exp Ther Med 2017;13:395-400. [PMID: 28352306 DOI: 10.3892/etm.2016.3966] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
13 Hisamatsu T, Ono N, Imaizumi A, Mori M, Suzuki H, Uo M, Hashimoto M, Naganuma M, Matsuoka K, Mizuno S. Decreased Plasma Histidine Level Predicts Risk of Relapse in Patients with Ulcerative Colitis in Remission. PLoS One. 2015;10:e0140716. [PMID: 26474176 DOI: 10.1371/journal.pone.0140716] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
14 Alsahli S, Al Anazi A, Al Hatlani MM, Kashgari A, Al Sufiani F, Alfadhel M, Al Mutairi F. Severe Crohn's Disease Manifestations in a Child with Cystathionine β-Synthase Deficiency. ACG Case Rep J 2018;5:e93. [PMID: 30775396 DOI: 10.14309/crj.2018.93] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Kim JM, Cheon JH. Pathogenesis and clinical perspectives of extraintestinal manifestations in inflammatory bowel diseases. Intest Res 2020;18:249-64. [PMID: 32295331 DOI: 10.5217/ir.2019.00128] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
16 Karmadonova NA, Shilova AN, Kozyreva VS, Subbotovskaya AI, Klevanets JE, Karpenko AA. Association of folate metabolism gene polymorphisms and pulmonary embolism: A case-control study of West-Siberian population. Thromb Res 2015;135:788-95. [PMID: 25754229 DOI: 10.1016/j.thromres.2014.11.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
17 Yang P, Wang L, Tang X, Liang Y. The methylenetetrahydrofolate reductase 1298 A>C polymorphism is associated with an increased risk of inflammatory bowel disease: evidence from a meta-analysis. Expert Rev Clin Immunol 2021;17:1221-9. [PMID: 34528870 DOI: 10.1080/1744666X.2021.1982384] [Reference Citation Analysis]
18 Benvenuti E, Pierini A, Gori E, Bottero E, Pietra M, Lippi I, Meucci V, Marchetti V. Serum homocysteine concentration in dogs with immunosuppressant-responsive enteropathy. J Vet Sci 2020;21:e47. [PMID: 32735090 DOI: 10.4142/jvs.2020.21.e47] [Reference Citation Analysis]
19 Asadzadeh-Aghdaei H, Mashayekhi K, Koushki K, Azimzadeh P, Rostami-Nejad M, Amani D, Chaleshi V, Haftcheshmeh SM, Sahebkar A, Zali MR. V617F-independent upregulation of JAK2 gene expression in patients with inflammatory bowel disease. J Cell Biochem 2019;120:15746-55. [PMID: 31069840 DOI: 10.1002/jcb.28844] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
20 Bollen L, Vande Casteele N, Peeters M, Bessonov K, Van Steen K, Rutgeerts P, Ferrante M, Hoylaerts MF, Vermeire S, Gils A. Short-term Effect of Infliximab Is Reflected in the Clot Lysis Profile of Patients with Inflammatory Bowel Disease: A Prospective Study. Inflammatory Bowel Diseases 2015;21:570-8. [DOI: 10.1097/mib.0000000000000301] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
21 Stadnicki A, Stadnicka I. Venous and arterial thromboembolism in patients with inflammatory bowel diseases. World J Gastroenterol 2021; 27(40): 6757-6774 [PMID: 34790006 DOI: 10.3748/wjg.v27.i40.6757] [Reference Citation Analysis]
22 Pan Y, Liu Y, Guo H, Jabir MS, Liu X, Cui W, Li D. Associations between Folate and Vitamin B12 Levels and Inflammatory Bowel Disease: A Meta-Analysis. Nutrients 2017;9:E382. [PMID: 28406440 DOI: 10.3390/nu9040382] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 7.8] [Reference Citation Analysis]
23 Thomas A, Klein MS, Stevens AP, Reinders Y, Hellerbrand C, Dettmer K, Gronwald W, Oefner PJ, Reinders J. Changes in the hepatic mitochondrial and membrane proteome in mice fed a non-alcoholic steatohepatitis inducing diet. J Proteomics. 2013;80C:107-122. [PMID: 23313215 DOI: 10.1016/j.jprot.2012.12.027] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
24 MacFarlane AJ, Behan NA, Matias FM, Green J, Caldwell D, Brooks SP. Dietary folate does not significantly affect the intestinal microbiome, inflammation or tumorigenesis in azoxymethane-dextran sodium sulphate-treated mice. Br J Nutr. 2013;109:630-638. [PMID: 23021249 DOI: 10.1017/s0007114512001857] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
25 Wennogle SA, Olver CS, Shropshire SB. Coagulation status, fibrinolysis, and platelet dynamics in dogs with chronic inflammatory enteropathy. J Vet Intern Med 2021;35:892-901. [PMID: 33665845 DOI: 10.1111/jvim.16092] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Stojanović M, Šćepanović L, Mitrović D, Šćepanović V, Šćepanović R, Djuric M, Ilić S, Šćepanović T, Djuric D. Different pathways involved in the stimulatory effects of homocysteine on rat duodenal smooth muscle. Acta Veterinaria 2017;67:254-70. [DOI: 10.1515/acve-2017-0021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
27 Olivera PA, Zuily S, Kotze PG, Regnault V, Al Awadhi S, Bossuyt P, Gearry RB, Ghosh S, Kobayashi T, Lacolley P, Louis E, Magro F, Ng SC, Papa A, Raine T, Teixeira FV, Rubin DT, Danese S, Peyrin-Biroulet L. International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34453143 DOI: 10.1038/s41575-021-00492-8] [Reference Citation Analysis]
28 Zhu S, Li J, Bing Y, Yan W, Zhu Y, Xia B, Chen M. Diet-Induced Hyperhomocysteinaemia Increases Intestinal Inflammation in an Animal Model of Colitis. ECCOJC 2015;9:708-19. [DOI: 10.1093/ecco-jcc/jjv094] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
29 Peluso R, Di Minno MN, Iervolino S, Manguso F, Tramontano G, Ambrosino P, Esposito C, Scalera A, Castiglione F, Scarpa R. Enteropathic spondyloarthritis: from diagnosis to treatment. Clin Dev Immunol. 2013;2013:631408. [PMID: 23690825 DOI: 10.1155/2013/631408] [Cited by in Crossref: 41] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
30 Cullen CE, Carter GT, Weiss MD, Grant PA, Saperstein DS. Hypohomocysteinemia: a potentially treatable cause of peripheral neuropathology? Phys Med Rehabil Clin N Am 2012;23:59-65, x. [PMID: 22239874 DOI: 10.1016/j.pmr.2011.11.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
31 Karban A, Feldman T, Waterman M, Leiba R, Efrati E. The association of the MTHFR C677T polymorphism with inflammatory bowel diseases in the Israeli Jewish population: An example of genetic heterogeneity. Medicine (Baltimore) 2016;95:e5611. [PMID: 28002332 DOI: 10.1097/MD.0000000000005611] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
32 Zhang R, Ma YP, Liu WT. Effect of maternal methyl donor deficient diet on experimental colitis in rat offsprings. Shijie Huaren Xiaohua Zazhi 2017; 25(31): 2791-2797 [DOI: 10.11569/wcjd.v25.i31.2791] [Reference Citation Analysis]
33 Schicho R, Marsche G, Storr M. Cardiovascular complications in inflammatory bowel disease. Curr Drug Targets. 2015;16:181-188. [PMID: 25642719 DOI: 10.2174/1389450116666150202161500] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 5.2] [Reference Citation Analysis]
34 Schicho R, Marsche G, Storr M. Cardiovascular complications in inflammatory bowel disease. Curr Drug Targets. 2015;16:181-188. [PMID: 25642719 DOI: 10.2174/138945011666650202161500] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Gao X, Li J, Chen M. Effect of Homocysteine on the Differentiation of CD4+ T Cells into Th17 Cells. Dig Dis Sci 2018;63:3339-47. [PMID: 29974377 DOI: 10.1007/s10620-018-5177-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
36 Kohoutova D, Moravkova P, Kruzliak P, Bures J. Thromboembolic complications in inflammatory bowel disease. J Thromb Thrombolysis 2015;39:489-98. [DOI: 10.1007/s11239-014-1129-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
37 Lin H, Bai Z, Meng F, Wu Y, Luo L, Shukla A, Yoshida EM, Guo X, Qi X. Epidemiology and Risk Factors of Portal Venous System Thrombosis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021;8:744505. [PMID: 35111772 DOI: 10.3389/fmed.2021.744505] [Reference Citation Analysis]
38 Purnak T, Yuksel O. Overview of venous thrombosis in inflammatory bowel disease. Inflamm Bowel Dis 2015;21:1195-203. [PMID: 25581828 DOI: 10.1097/MIB.0000000000000274] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]
39 Paul R, Borah A. The potential physiological crosstalk and interrelationship between two sovereign endogenous amines, melatonin and homocysteine. Life Sci 2015;139:97-107. [PMID: 26281918 DOI: 10.1016/j.lfs.2015.07.031] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
40 Djuric D, Jakovljevic V, Zivkovic V, Srejovic I. Homocysteine and homocysteine-related compounds: an overview of the roles in the pathology of the cardiovascular and nervous systems. Can J Physiol Pharmacol 2018;96:991-1003. [PMID: 30130426 DOI: 10.1139/cjpp-2018-0112] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 7.5] [Reference Citation Analysis]
41 Gioxari A, Amerikanou C, Papada E, Zioga E, Georgoulis AD, Bamias G, Kaliora AC. Serum Vitamins D, B9 and B12 in Greek Patients with Inflammatory Bowel Diseases. Nutrients 2020;12:E3734. [PMID: 33291539 DOI: 10.3390/nu12123734] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
42 Al Mutairi F. Hyperhomocysteinemia: Clinical Insights. J Cent Nerv Syst Dis 2020;12:1179573520962230. [PMID: 33100834 DOI: 10.1177/1179573520962230] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
43 Ding H, Mei Q, Gan HZ, Cao LY, Liu XC, Xu JM. Effect of homocysteine on intestinal permeability in rats with experimental colitis, and its mechanism. Gastroenterol Rep (Oxf) 2014;2:215-20. [PMID: 24787389 DOI: 10.1093/gastro/gou022] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
44 Koutroubakis IE. The relationship between coagulation state and inflammatory bowel disease: current understanding and clinical implications. Expert Rev Clin Immunol. 2015;11:479-488. [PMID: 25719625 DOI: 10.1586/1744666x.2015.1019475] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
45 Zanoli L, Mikhailidis DP, Bruno RM, Abreu MT, Danese S, Eliakim R, Gionchetti P, Katsanos KH, Kirchgesner J, Koutroubakis IE, Kucharzik T, Lakatos PL, Nguyen GC, Papa A, Vavricka SR, Wilkinson IB, Boutouyrie P. Aortic Stiffening Is an Extraintestinal Manifestation of Inflammatory Bowel Disease: Review of the Literature and Expert Panel Statement. Angiology 2020;71:689-97. [DOI: 10.1177/0003319720918509] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
46 Giannotta M, Tapete G, Emmi G, Silvestri E, Milla M. Thrombosis in inflammatory bowel diseases: what's the link? Thromb J. 2015;13:14. [PMID: 25866483 DOI: 10.1186/s12959-015-0044-2] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 7.7] [Reference Citation Analysis]
47 Pepe M, Carulli E, Forleo C, Moscarelli M, Di Cillo O, Bortone AS, Nestola PL, Biondi-Zoccai G, Giordano A, Favale S. Inflammatory Bowel Disease and Acute Coronary Syndromes: From Pathogenesis to the Fine Line Between Bleeding and Ischemic Risk. Inflamm Bowel Dis 2021;27:725-31. [PMID: 32592478 DOI: 10.1093/ibd/izaa160] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
48 Harb Z, Deckert V, Bressenot AM, Christov C, Guéant-Rodriguez RM, Raso J, Alberto JM, de Barros JP, Umoret R, Peyrin-Biroulet L, Lagrost L, Bronowicki JP, Guéant JL. The deficit in folate and vitamin B12 triggers liver macrovesicular steatosis and inflammation in rats with dextran sodium sulfate-induced colitis. J Nutr Biochem 2020;84:108415. [PMID: 32645655 DOI: 10.1016/j.jnutbio.2020.108415] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
49 Gan GH, Yang LM, Wang J. Thrombotic mechanism and anticoagulant therapy in inflammatory bowel disease patients. Shijie Huaren Xiaohua Zazhi 2016; 24(2): 236-241 [DOI: 10.11569/wcjd.v24.i2.236] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Keshteli AH, Baracos VE, Madsen KL. Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases: A review. World J Gastroenterol 2015; 21(4): 1081-1090 [PMID: 25632180 DOI: 10.3748/wjg.v21.i4.1081] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.9] [Reference Citation Analysis]
51 Landman C, Nahon S, Cosnes J, Bouhnik Y, Brixi-Benmansour H, Bouguen G, Colombel JF, Savoye G, Coffin B, Abitbol V. Portomesenteric vein thrombosis in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:582-589. [PMID: 23385240 DOI: 10.1097/mib.0b013e31827eea5f] [Cited by in Crossref: 25] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
52 Casella G, Antonelli E, Di Bella C, Di Marco E, Piatti M, Villanacci V, Bologna S, Baldini V, Bassotti G. Hyperhomocysteinemia in patients with Crohn's disease. Tech Coloproctol 2013;17:497-500. [PMID: 23471541 DOI: 10.1007/s10151-013-0992-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
53 Stojanović M, Šćepanović L, Todorović D, Mitrović D, Šćepanović V, Šćepanović R, Ilić S, Šćepanović T, Borović ML, Milićević Ž, Dragutinović V, Borozan S, Lalić I, Despotović S, Djuric D. Suppression of methionine-induced colon injury of young rats by cysteine and N-acetyl-l-cysteine. Mol Cell Biochem 2018;440:53-64. [DOI: 10.1007/s11010-017-3155-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
54 Nuñez P, García Mateo S, Quera R, Gomollón F. Inflammatory bowel disease and the risk of cardiovascular diseases. Gastroenterol Hepatol 2021;44:236-42. [PMID: 33223261 DOI: 10.1016/j.gastrohep.2020.09.002] [Reference Citation Analysis]
55 Familtseva A, Kalani A, Chaturvedi P, Tyagi N, Metreveli N, Tyagi SC. Mitochondrial mitophagy in mesenteric artery remodeling in hyperhomocysteinemia. Physiol Rep 2014;2:e00283. [PMID: 24771691 DOI: 10.14814/phy2.283] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
56 Jezernik G, Potočnik U. Comprehensive genetic study of fatty acids helps explain the role of noncoding inflammatory bowel disease associated SNPs and fatty acid metabolism in disease pathogenesis. Prostaglandins, Leukotrienes and Essential Fatty Acids 2018;130:1-10. [DOI: 10.1016/j.plefa.2018.02.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
57 Kim JE, Lee HJ, Lee JS, Whang KU, Park YL, Lee SY, Kim HJ. Association between Homocysteine Levels and Psoriasis: A Meta-Analysis. Ann Dermatol 2019;31:378-86. [PMID: 33911615 DOI: 10.5021/ad.2019.31.4.378] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
58 Morís G. Inflammatory bowel disease: An increased risk factor for neurologic complications. World J Gastroenterol 2014; 20(5): 1228-1237 [PMID: 24574797 DOI: 10.3748/wjg.v20.i5.1228] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 41] [Article Influence: 6.5] [Reference Citation Analysis]
59 Kirchgesner J, Nyboe Andersen N, Carrat F, Jess T, Beaugerie L; BERENICE study group. Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study. Gut 2020;69:852-8. [PMID: 31446428 DOI: 10.1136/gutjnl-2019-318932] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 11.5] [Reference Citation Analysis]
60 Singh S, Kullo IJ, Pardi DS, Loftus EV. Epidemiology, risk factors and management of cardiovascular diseases in IBD. Nat Rev Gastroenterol Hepatol. 2015;12:26-35. [PMID: 25446727 DOI: 10.1038/nrgastro.2014.202] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 7.5] [Reference Citation Analysis]
61 Kirchgesner J, Beaugerie L, Carrat F, Andersen NN, Jess T, Schwarzinger M; BERENICE study group. Increased risk of acute arterial events in young patients and severely active IBD: a nationwide French cohort study. Gut 2018;67:1261-8. [PMID: 28647686 DOI: 10.1136/gutjnl-2017-314015] [Cited by in Crossref: 58] [Cited by in F6Publishing: 46] [Article Influence: 14.5] [Reference Citation Analysis]
62 Tan VP, Chung A, Yan BP, Gibson PR. Venous and arterial disease in inflammatory bowel disease. J Gastroenterol Hepatol. 2013;28:1095-1113. [PMID: 23662785 DOI: 10.1111/jgh.12260] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
63 Magro F, Soares JB, Fernandes D. Venous thrombosis and prothrombotic factors in inflammatory bowel disease. World J Gastroenterol 2014; 20(17): 4857-4872 [PMID: 24803797 DOI: 10.3748/wjg.v20.i17.4857] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 50] [Article Influence: 7.0] [Reference Citation Analysis]
64 Grewal HK, Bansal M, Garg A, Kasliwal RR, Bhan A, Gautam D. Left Ventricular Thrombus and Cardioembolic Stroke in a Patient with Ulcerative Colitis: A Case Report. Saudi J Med Med Sci 2021;9:67-70. [PMID: 33519347 DOI: 10.4103/sjmms.sjmms_525_19] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
65 Ott C, Schölmerich J. Extraintestinal manifestations and complications in IBD. Nat Rev Gastroenterol Hepatol. 2013;10:585-595. [PMID: 23835489 DOI: 10.1038/nrgastro.2013.117] [Cited by in Crossref: 124] [Cited by in F6Publishing: 115] [Article Influence: 13.8] [Reference Citation Analysis]
66 Ferguson LR. Potential value of nutrigenomics in Crohn's disease. Nat Rev Gastroenterol Hepatol 2012;9:260-70. [PMID: 22410431 DOI: 10.1038/nrgastro.2012.41] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
67 Schalinske KL, Smazal AL. Homocysteine imbalance: a pathological metabolic marker. Adv Nutr 2012;3:755-62. [PMID: 23153729 DOI: 10.3945/an.112.002758] [Cited by in Crossref: 108] [Cited by in F6Publishing: 100] [Article Influence: 10.8] [Reference Citation Analysis]
68 Rondanelli M, Lamburghini S, Faliva MA, Peroni G, Riva A, Allegrini P, Spadaccini D, Gasparri C, Iannello G, Infantino V, Alalwan TA, Perna S, Miccono A. A food pyramid, based on a review of the emerging literature, for subjects with inflammatory bowel disease. Endocrinol Diabetes Nutr (Engl Ed) 2021;68:17-46. [PMID: 32499202 DOI: 10.1016/j.endinu.2020.01.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
69 Li J, Xu F, Zeng R, Gong H, Lan Y. Plasma Homocysteine, Serum Folic Acid, Serum Vitamin B12, Serum Vitamin B6, MTHFR, and Risk of Normal-Tension Glaucoma. J Glaucoma 2016;25:e94-8. [PMID: 26171850 DOI: 10.1097/IJG.0000000000000269] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]